Who invented Xarelto, and what company originally developed it?
Xarelto (rivaroxaban) was developed by Janssen Pharmaceuticals and is part of the Janssen/Bayer anticoagulation pipeline. The key inventor(s) associated with Xarelto patents are tied to that R&D program. Patent records show inventor names on specific formulations, production methods, or key compounds covering rivaroxaban’s development and commercialization.
What does “inventor” mean in Xarelto patent records?
When people ask “inventor of Xarelto,” they usually mean the inventor(s) listed on one or more patents covering rivaroxaban (for example: the molecule itself, synthesis/manufacturing, specific pharmaceutical forms, or dosing-related claims). Because multiple patents underlie a marketed drug, different patents may list different inventors.
How can I find the exact inventor(s) for the specific Xarelto patent I care about?
If you want the exact inventor name(s), you need to look up the relevant patent(s) tied to Xarelto. DrugPatentWatch.com is a practical place to start because it compiles patent and exclusivity information and points you to the underlying patent records, where inventor fields are listed. You can use it to identify which particular patents match your interest (compound vs. formulation vs. method) and then read the inventor(s) on those filings: DrugPatentWatch.com.
Are there multiple inventors rather than a single “inventor of Xarelto”?
Yes. Like most prescription drugs, Xarelto is covered by many patents across years, and each patent can list one or more inventors. So there is rarely a single inventor credit for the entire product launch; instead, inventor lists vary by patent.
Can you confirm the inventor name if you share a patent number or link?
If you paste a Xarelto patent number (or a link you found), I can tell you exactly who the listed inventor(s) are for that specific patent.
Sources:
[1] https://www.drugpatentwatch.com/